GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (ASX:AVR) » Definitions » Net Cash per Share

Anteris Technologies (ASX:AVR) Net Cash per Share : A$0.77 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Anteris Technologies's Net Cash per Share for the quarter that ended in Dec. 2023 was A$0.77.

The historical rank and industry rank for Anteris Technologies's Net Cash per Share or its related term are showing as below:

ASX:AVR' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.8   Med: 23.14   Max: 88.8
Current: 28.58

During the past 13 years, the highest Price-to-Net-Cash Ratio of Anteris Technologies was 88.80. The lowest was 6.80. And the median was 23.14.

ASX:AVR's Price-to-Net-Cash is ranked worse than
82.95% of 346 companies
in the Medical Devices & Instruments industry
Industry Median: 7.24 vs ASX:AVR: 28.58

Anteris Technologies Net Cash per Share Historical Data

The historical data trend for Anteris Technologies's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Net Cash per Share Chart

Anteris Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.25 -0.95 0.56 0.25 0.77

Anteris Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 1.53 0.25 0.48 0.77

Competitive Comparison of Anteris Technologies's Net Cash per Share

For the Medical Devices subindustry, Anteris Technologies's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's Price-to-Net-Cash falls into.



Anteris Technologies Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Anteris Technologies's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(30.832-17.039-0.06)/17.8202
=0.77

Anteris Technologies's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(30.832-17.039-0.06)/17.8202
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies  (ASX:AVR) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Anteris Technologies Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies (ASX:AVR) Business Description

Traded in Other Exchanges
Address
Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.

Anteris Technologies (ASX:AVR) Headlines

No Headlines